Related Experiment Video

Updated: May 30, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach

Shubin W Shahab1, Lilya V Matyunina, Roman Mezencev

  • 1School of Biology, Georgia Institute of Technology, Atlanta, Georgia, United States of America.

Plos One
|August 4, 2011
PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression but their therapeutic use in cancer is complex. This study found limited inverse correlation between miRNA and mRNA levels in ovarian cancer, highlighting indirect cellular processes affecting miRNA function.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are short regulatory RNAs impacting gene expression.
  • Aberrant miRNA expression is linked to various diseases, notably cancer.
  • miRNAs are investigated for cancer therapy due to their gene regulation roles.

Purpose of the Study:

  • To evaluate the predictive accuracy of current miRNA target prediction models in vivo.
  • To investigate the relationship between miRNA and messenger RNA (mRNA) levels in ovarian cancer cells.
  • To understand the complexities of miRNA-mediated gene regulation in the tumor microenvironment.

Main Methods:

  • Quantitative analysis of miRNA and mRNA levels in laser-captured micro-dissected ovarian cancer epithelial cells (CEPI) and ovarian surface epithelial cells (OSE).
  • Comparison of observed miRNA-mRNA correlations against predictions from computational target identification algorithms.
  • Assessment of factors influencing miRNA regulatory efficacy in vivo.

Main Results:

  • A low inverse correlation (approximately 11%) was observed between miRNA levels and their predicted mRNA targets in vivo.
  • This discrepancy is attributed to indirect cellular mechanisms rather than inaccurate miRNA target predictions.
  • Findings suggest complex regulatory networks influencing miRNA function within tumor cells.

Conclusions:

  • Current miRNA target prediction models show limited accuracy in predicting in vivo regulatory outcomes.
  • Indirect cellular processes significantly modulate miRNA effects in the context of ovarian cancer.
  • Further research into these complexities is crucial for realizing the therapeutic potential of miRNAs in cancer treatment.

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...